Advances in the clinical translation of nanotechnology Journal Article
| Authors: | Scheinberg, D. A.; Grimm, J.; Heller, D. A.; Stater, E. P.; Bradbury, M.; McDevitt, M. R. |
| Article Title: | Advances in the clinical translation of nanotechnology |
| Abstract: | The use of novel materials in the nano-scale size range for applications in devices, drugs and diagnostic agents comes with a number of new opportunities, and also serious challenges to human applications. The larger size of particulate-based agents, as compared to traditional drugs, allows for the significant advantages of multivalency and multi-functionality. However, the human use of nanomaterials requires a thorough understanding of the biocompatibility of the synthetic molecules and their complex pharmacology. Possible toxicities created by the unusual properties of the nanoparticles are neither well-understood, nor predictable yet. A key to the successful use of the burgeoning field of nanomaterials as diagnostic and therapeutic agents will be to appropriately match the biophysical features of the particle to the disease system to be evaluated or treated. © 2017 Elsevier Ltd |
| Keywords: | diagnosis; biocompatibility; nanotechnology; novel materials; multivalency; clinical translation; therapeutic agents; nanostructured materials; multifunctionality; diagnostic agents; nano scale; synthetic molecules |
| Journal Title: | Current Opinion in Biotechnology |
| Volume: | 46 |
| ISSN: | 0958-1669 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-08-01 |
| Start Page: | 66 |
| End Page: | 73 |
| Language: | English |
| DOI: | 10.1016/j.copbio.2017.01.002 |
| PROVIDER: | scopus |
| PUBMED: | 28187340 |
| PMCID: | PMC5544552 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 2 March 2017 -- Source: Scopus |
Altmetric
Citation Impact
Related MSK Work